Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxofylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Industrial Intermediates, Chlorinated Solvents, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.As of 25 May 2026, AAREY DRUGS & PHARM LTD share price is ₹82.40. The stock opened at ₹83.73, compared to its previous close of ₹83.74. During today's trading session, AAREY DRUGS & PHARM LTD share price moved in the range of ₹81.50 to ₹83.73, with an average price of ₹82.62 for the day. Looking at its last 52-week, the stock has touched a low of ₹81.50 and a high of ₹83.73. On the performance front, AAREY DRUGS & PHARM LTD share price has declined by 9.64% over the last six months and is up 56.20% on a year-on-year basis.
The market capitalization of AAREY DRUGS & PHARM LTD is ₹241 Crs, with a P/E ratio of 70.3 and a dividend yield of 0.00%.